Contents

Search


rituximab/cyclophosphamide/vincristine (Oncocin)/prednisone (R-CVP)

A chemotherapy regimen for treatment of lymphomas. Dosage: - six 21-day cycles - rituximab (375 mg/m2) administered on day 1 of each cycle - on days 1-5 - cyclophosphamide (400 mg/m2) - vincristine (1 mg capped dose) - prednisone (40 mg/m2)

General

antineoplastic combination (combination chemotherapy)

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16, American College of Physicians, Philadelphia 2012

Components

cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271] prednisone (Deltasone, Orasone, Liquid Pred, Meticortin, Rayos) rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni) vincristine; 22-oxovincaleukoblastine; leurocristine (Oncovin, Vincasar PFS)